Adverum Biotechnologies, Inc.
ADVM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $26 | $42 | $49 | $61 |
| Short-Term Investments | $0 | $2 | $34 | $65 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $4 | $6 | $6 |
| Total Curr. Assets | $29 | $48 | $89 | $131 |
| Property Plant & Equip (Net) | $39 | $44 | $45 | $45 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $2 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $3 | $3 | $3 |
| Total NC Assets | $43 | $48 | $48 | $49 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $72 | $96 | $138 | $180 |
| Liabilities | – | – | – | – |
| Payables | $12 | $5 | $2 | $2 |
| Short-Term Debt | $6 | $7 | $7 | $6 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $26 | $19 | $16 | $15 |
| Total Curr. Liab. | $45 | $31 | $25 | $23 |
| LT Debt | $83 | $85 | $86 | $86 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $83 | $85 | $86 | $86 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $83 | $92 | $93 | $92 |
| Total Liabilities | $128 | $116 | $111 | $109 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,211 | -$1,163 | -$1,114 | -$1,067 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $1,156 | $1,143 | $1,141 | $1,138 |
| Total Equity | -$56 | -$20 | $26 | $71 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $72 | $96 | $138 | $180 |
| Net Debt | $63 | $50 | $44 | $31 |